The initial success of Viagra undeniably reshaped the drug landscape, but betting in companies strongly reliant on off-patent versions presents a complex picture. Although early profits were substantial, the expiration of patents and the appearance of less expensive alternatives have diminished the customer base. Consequently, a thorough evaluation